3.14 -0.02 (-0.63%)

New 52W Low in past week

671.0K XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Terns Pharmaceuticals Inc is on 21 Mar 2025 for the purpose of Terns Pharmaceuticals Inc Annual Report for 2024 See details


Insider Trading disclosures for Terns Pharmaceuticals Inc

The latest disclosure was made by Andrew Gengos in Terns Pharmaceuticals Inc where a trade of 750,000 Stock Option (Right to Buy) done was reported to US exchanges on Feb. 24, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Andrew Gengos Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2025 750,000 750,000 - - Stock Option (Right to Buy)
Robert W. Azelby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2025 90,000 90,000 - - Stock Option (Right to Buy)
Jeffrey B. Kindler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2025 10,657 10,657 - - Stock Option (Right to Buy)
David Fellows Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2025 18,650 18,650 - - Stock Option (Right to Buy)
Radhika Tripuraneni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2025 10,657 10,657 - - Stock Option (Right to Buy)
Hongbo Lu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2025 10,657 10,657 - - Stock Option (Right to Buy)
Jill M. Quigley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2025 10,657 10,657 - - Stock Option (Right to Buy)
Amy Burroughs Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 5.11 per share. 30 Jan 2025 510 19,609 - 5.1 2,606 Common Stock
Amy Burroughs Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2025 1,075,000 1,075,000 - - Stock Option (Right to Buy)
Emil T. Kuriakose Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2025 485,000 485,000 - - Stock Option (Right to Buy)
Melita Sun Jung Chief Business Officer Purchase of securities on an exchange or from another person at price $ 5.11 per share. 30 Jan 2025 2,250 2,250 - 5.1 11,498 Common Stock
Melita Sun Jung Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2025 325,000 325,000 - - Stock Option (Right to Buy)
Mark J. Vignola Chief Financial Officer 02 Jan 2025 8,129 83,811 - 5.7 46,524 Common Stock
Mark J. Vignola Chief Financial Officer 02 Jan 2025 9,059 74,752 - 5.8 52,500 Common Stock
Jill M. Quigley Director Sale of securities on an exchange or to another person at price $ 5.72 per share. 02 Jan 2025 6,240 8,760 - 5.7 35,702 Common Stock
Jill M. Quigley Director Sale of securities on an exchange or to another person at price $ 5.79 per share. 02 Jan 2025 8,760 0 - 5.8 50,758 Common Stock
Emil T. Kuriakose Chief Medical Officer Sale of securities on an exchange or to another person at price $ 5.71 per share. 02 Jan 2025 4,481 54,269 - 5.7 25,607 Common Stock
Emil T. Kuriakose Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2024 120,000 120,000 - - Stock Option (Right to Buy)
Amy Burroughs Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 7.15 per share. 05 Dec 2024 15,450 19,099 - 7.2 110,468 Common Stock
Heather D. Turner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2024 64,000 64,000 - - Stock Option (Right to Buy)
Hongbo Lu Director Purchase of securities on an exchange or from another person at price $ 10.50 per share. 12 Sep 2024 285,714 476,190 - 10.5 2,999,997 Common Stock
Hongbo Lu Director Purchase of securities on an exchange or from another person at price $ 10.50 per share. 12 Sep 2024 190,476 190,476 - 10.5 1,999,998 Common Stock
Mark J. Vignola Chief Financial Officer 10 Sep 2024 10,000 55,000 - - Stock Option (Right to Buy)
Mark J. Vignola Chief Financial Officer 10 Sep 2024 10,000 91,940 - 11 110,000 Common Stock
Mark J. Vignola Chief Financial Officer 10 Sep 2024 10,000 101,940 - 5.4 53,600 Common Stock
Jill M. Quigley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Sep 2024 17,235 0 - - Stock Option (Right to Buy)
Jill M. Quigley Director Sale of securities on an exchange or to another person at price $ 10.00 per share. 09 Sep 2024 17,235 15,000 - 10 172,350 Common Stock
Jill M. Quigley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.82 per share. 09 Sep 2024 17,235 32,235 - 1.8 31,368 Common Stock
Jill M. Quigley Director Sale of securities on an exchange or to another person at price $ 7.68 per share. 01 Aug 2024 6,143 23,857 - 7.7 47,148 Common Stock
Jill M. Quigley Director Sale of securities on an exchange or to another person at price $ 7.50 per share. 01 Aug 2024 8,857 15,000 - 7.5 66,432 Common Stock
Carl L. Gordon Director, Ten Percent Owner 15 Jul 2024 39,433 4,843,421 - 10 394,330 Common Stock
Carl L. Gordon Director, Ten Percent Owner 15 Jul 2024 623 755,635 - 10 6,230 Common Stock
Carl L. Gordon Director, Ten Percent Owner 15 Jul 2024 556 1,967,924 - 10 5,560 Common Stock
Carl L. Gordon Director, Ten Percent Owner 15 Jul 2024 4,009 4,839,412 - 10 40,090 Common Stock
Carl L. Gordon Director, Ten Percent Owner 15 Jul 2024 6,142 756,258 - 10 61,420 Common Stock
Carl L. Gordon Director, Ten Percent Owner 15 Jul 2024 5,401 1,968,480 - 10 54,010 Common Stock
Jill M. Quigley Director Sale of securities on an exchange or to another person at price $ 10.00 per share. 15 Jul 2024 14,365 30,000 - 10.0 143,660 Common Stock
Jill M. Quigley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 400 17,235 - - Stock Option (Right to Buy)
Jill M. Quigley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 14,365 17,635 - - Stock Option (Right to Buy)
Jill M. Quigley Director Sale of securities on an exchange or to another person at price $ 10.00 per share. 15 Jul 2024 400 30,000 - 10 4,000 Common Stock
Jill M. Quigley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.82 per share. 15 Jul 2024 400 30,400 - 1.8 728 Common Stock
Jill M. Quigley Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.82 per share. 15 Jul 2024 14,365 44,365 - 1.8 26,144 Common Stock
Carl L. Gordon Director, Ten Percent Owner 01 Jul 2024 4,676 4,676 - - Stock Option (Right to Buy)
Jeffrey B. Kindler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 4,676 4,676 - - Stock Option (Right to Buy)
David Fellows Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 8,183 8,183 - - Stock Option (Right to Buy)
Radhika Tripuraneni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 4,676 4,676 - - Stock Option (Right to Buy)
Hongbo Lu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 4,676 4,676 - - Stock Option (Right to Buy)
Ann E. Taylor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2024 4,676 4,676 - - Stock Option (Right to Buy)
Carl L. Gordon Director, Ten Percent Owner 10 Jun 2024 32,000 32,000 - - Stock Option (Right to Buy)
Jeffrey B. Kindler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 32,000 32,000 - - Stock Option (Right to Buy)
David Fellows Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 32,000 32,000 - - Stock Option (Right to Buy)
Radhika Tripuraneni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 32,000 32,000 - - Stock Option (Right to Buy)
Hongbo Lu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 32,000 32,000 - - Stock Option (Right to Buy)
Jill M. Quigley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 32,000 32,000 - - Stock Option (Right to Buy)
Ann E. Taylor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 32,000 32,000 - - Stock Option (Right to Buy)
Seokho Yoon COO and General Counsel Purchase of securities on an exchange or from another person at price $ 4.44 per share. 31 May 2024 4,791 91,940 - 4.4 21,272 Common Stock
Mark J. Vignola Chief Financial Officer 31 May 2024 4,791 91,940 - 4.4 21,272 Common Stock
Melita Sun Jung Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2024 475,000 475,000 - - Stock Option (Right to buy)
Amy Burroughs Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 1,250,000 1,250,000 - - Stock Option (Right to buy)
Amy Burroughs Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 150,000 150,000 - - Restricted Stock Unit
Erin Quirk President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 150,000 150,000 - - Stock Option (Right to Buy)
Vignola Mark J. Chief Financial Officer 23 Jan 2024 137,500 137,500 - - Stock Option (Right to Buy)
Quirk Erin President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 75,000 75,000 - 0 Common Stock
Seokho Yoon COO and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 68,750 87,149 - 0 Common Stock
Jill M. Quigley Director, Sr. Advisor & Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 15,000 30,000 - 0 Common Stock
J. Vignola Mark Chief Financial Officer 23 Jan 2024 68,750 87,149 - 0 Common Stock
Yoon Seokho COO and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2024 137,500 137,500 - - Stock Option (Right to Buy)
Seokho Yoon COO and General Counsel Purchase of securities on an exchange or from another person at price $ 3.78 per share. 30 Nov 2023 743 18,399 - 3.8 2,809 Common Stock
Vignola J. Mark Chief Financial Officer 30 Nov 2023 743 18,399 - 3.8 2,809 Common Stock
Seokho Yoon COO and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 360,000 360,000 - - Stock Option (Right to Buy)
Seokho Yoon COO and General Counsel Purchase of securities on an exchange or from another person at price $ 1.33 per share. 01 Feb 2023 3 7,659 - 1.3 4 Common Stock
Senthil Sundaram Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 900,000 900,000 - - Stock Option (Right to Buy)
Senthil Sundaram Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.33 per share. 01 Feb 2023 3 7,659 - 1.3 4 Common Stock
Mark J. Vignola Chief Financial Officer 01 Feb 2023 360,000 360,000 - - Stock Option (Right to Buy)
Mark J. Vignola Chief Financial Officer 01 Feb 2023 3 7,659 - 1.3 4 Common Stock
Erin Quirk President, Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 600,000 600,000 - - Stock Option (Right to Buy)
Carl L. Gordon Director, Ten Percent Owner 23 Dec 2022 137,931 4,882,854 - 7.3 1,000,000 Common Stock
Hongbo Lu Director Purchase of securities on an exchange or from another person at price $ 7.25 per share. 23 Dec 2022 758,620 4,340,212 - 7.3 5,499,995 Common Stock
Hongbo Lu Director Purchase of securities on an exchange or from another person at price $ 3.60 per share. 07 Sep 2022 600,000 3,581,592 - 3.6 2,160,000 Common Stock
Carl L. Gordon Director, Ten Percent Owner 16 Aug 2022 2,470,200 4,744,923 - 2.4 5,977,884 Common Stock
Carl L. Gordon Director, Ten Percent Owner 16 Aug 2022 64,050 64,050 - - Pre-Funded Warrant
Carl L. Gordon Director, Ten Percent Owner 16 Aug 2022 38,450 38,450 - - Pre-Funded Warrant
Carl L. Gordon Director, Ten Percent Owner 16 Aug 2022 207,500 207,500 - - Pre-Funded Warrant
Carl L. Gordon Director, Ten Percent Owner 16 Aug 2022 762,400 762,400 - 2.4 1,845,008 Common Stock
Carl L. Gordon Director, Ten Percent Owner 16 Aug 2022 457,400 1,973,881 - 2.4 1,106,908 Common Stock
Hongbo Lu Director Purchase of securities on an exchange or from another person at price $ 2.42 per share. 12 Aug 2022 1,500,000 2,981,592 - 2.4 3,630,000 Common Stock
Hongbo Lu Director Purchase of securities on an exchange or from another person at price $ 2.98 per share. 12 Aug 2022 1,123,021 1,480,374 - 3.0 3,346,603 Common Stock
Hongbo Lu Director Purchase of securities on an exchange or from another person at price $ 2.99 per share. 12 Aug 2022 1,218 1,481,592 - 3.0 3,642 Common Stock
Hongbo Lu Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Aug 2022 1,500,000 1,500,000 - - Pre-funded Warrants (right to buy)
Radhika Tripuraneni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jul 2022 64,000 64,000 - - Stock Option (Right to Buy)
Kerry Strong Russell Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2022 240,000 240,000 - - Stock Option (Right to Buy)
Carl L. Gordon Director, Ten Percent Owner 16 Jun 2022 32,000 32,000 - - Stock Option (Right to Buy)
Jeffrey B. Kindler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 32,000 32,000 - - Stock Option (Right to Buy)
David Fellows Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 32,000 32,000 - - Stock Option (Right to Buy)
Hongbo Lu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 32,000 32,000 - - Stock Option (Right to Buy)
Jill M. Quigley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 32,000 32,000 - - Stock Option (Right to Buy)
Ann E. Taylor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 32,000 32,000 - - Stock Option (Right to Buy)
Seokho Yoon COO and General Counsel Purchase of securities on an exchange or from another person at price $ 1.47 per share. 31 May 2022 7,656 7,656 - 1.5 11,254 Common Stock
Senthil Sundaram Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.47 per share. 31 May 2022 7,656 7,656 - 1.5 11,254 Common Stock
Mark J. Vignola Chief Financial Officer 31 May 2022 7,656 7,656 - 1.5 11,254 Common Stock
Jeffrey B. Kindler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Sep 2021 22,000 22,000 - - Stock Option (Right to Buy)
Seokho Yoon COO and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Sep 2021 120,000 120,000 - - Stock Option (Right to Buy)
David Fellows Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Sep 2021 22,000 22,000 - - Stock Option (Right to Buy)
Senthil Sundaram Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Sep 2021 315,000 315,000 - - Stock Option (Right to Buy)
Mark J. Vignola Chief Financial Officer 28 Sep 2021 120,000 120,000 - - Stock Option (Right to Buy)
Jill M. Quigley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Sep 2021 22,000 22,000 - - Stock Option (Right to Buy)
Erin Quirk President and CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Sep 2021 142,500 142,500 - - Stock Option (Right to Buy)
Ann E. Taylor Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Sep 2021 44,000 44,000 - - Stock Option (Right to Buy)
Carl L Gordon Director, Ten Percent Owner 24 Feb 2021 25,000 25,000 - - Stock Option (Right to Buy)
Hongbo Lu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2021 25,000 25,000 - - Stock Option (Right to Buy)
Carl L Gordon Director, Ten Percent Owner 09 Feb 2021 190,000 1,516,481 - 17 3,230,000 Common Stock
Carl L Gordon Director, Ten Percent Owner 09 Feb 2021 612,196 0 - - Series C Preferred Stock
Carl L Gordon Director, Ten Percent Owner 09 Feb 2021 1,071,428 0 - - Series B Preferred Stock
Carl L Gordon Director, Ten Percent Owner 09 Feb 2021 714,285 0 - - Series B Preferred Stock
Carl L Gordon Director, Ten Percent Owner 09 Feb 2021 1,326,481 1,326,481 - - Common Stock
Carl L Gordon Director, Ten Percent Owner 09 Feb 2021 1,989,723 1,989,723 - - Common Stock
Carl L Gordon Director, Ten Percent Owner 09 Feb 2021 285,000 2,274,723 - 17 4,845,000 Common Stock
Carl L Gordon Director, Ten Percent Owner 09 Feb 2021 918,295 0 - - Series C Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures